Back to search

Sweden· SE-19990602000011

Exelon 2 mg/ml Oral lösning

A medicinal product containing rivastigmine, registered in Sweden by Novartis Europharm Limited.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedExelon 2 mg/ml Oral lösningATC—REGISTER NO.SE-19990602000011PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Rivastigmine
Manufacturer
Novartis Europharm Limited
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19990602000011

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rivastigmine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rivastigmine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Nimgista, Rivagelan
  • Belgium · Rivastigmin Sandoz, Rivastigmine Viatris
  • Bulgaria · Ридаксин
  • Germany · Demelora, Rivastigmin
  • Denmark · Rigmin, Rivastigmin Orion
  • Spain · Alzerta, Alzerta Dos Por Semana
  • Finland · Rivastigmin Orion, Rivastigmine Sandoz
  • France · Rivastigmine Arrow, Rivastigmine Biogaran
  • United Kingdom (Northern Ireland) · Almuriva, Alzest
  • Greece · Alapril, Balaxon
  • Iceland · Exelon, Nimvastid
  • Italy · Demelora, Rivastigmina Aurobindo
  • Liechtenstein · Exelon, Rivastigmine 1 A Pharma
  • Malta · Rivastigmine Aurobindo
  • Netherlands · Ristidic, Rivastgimine Neuraxpharm
  • Norway · Exelon, Nimvastid
  • Poland · Atmina, Evertas
  • Portugal · Nervopan, Rivastigmina Alter
  • Romania · Evertas, Ridaxin
  • Slovenia · Rivastigmin Teva, Rivastigmin Teva B.V.
  • Slovakia · Ristidic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4e5814b3-4795-4037-8756-91880ed87c26
GET /v1/drugs/4e5814b3-4795-4037-8756-91880ed87c26?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "19990602000011",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19990602000011",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/exelon-epar-product-information_sv.pdf"
}

See everything about rivastigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.